Revance Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 29, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	109,998	126,898	66,335	37,403	38,323	18,840	Upgrade
Market Cap Growth	15.75%	91.30%	77.35%	-2.40%	103.41%	31.68%	Upgrade
Last Close Price	126.82	143.76	73.92	42.78	64.10	31.44	Upgrade
PE Ratio	64.19	42.71	19.92	-	9.42	11.86	Upgrade
PS Ratio	6.02	4.97	3.93	7.25	1.76	2.71	Upgrade
PB Ratio	1.87	2.12	1.26	0.72	0.75	0.56	Upgrade
P/FCF Ratio	-	20.19	-	-	-	-	Upgrade
P/OCF Ratio	-	19.76	-	-	-	-	Upgrade
Debt / Equity Ratio	0.75	0.83	0.86	0.82	0.69	0.84	Upgrade
Debt / FCF Ratio	-	7.89	-	-	-	-	Upgrade
Asset Turnover	-	0.08	0.06	0.02	0.14	0.12	Upgrade
Quick Ratio	-	0.73	1.03	1.01	0.91	2.03	Upgrade
Current Ratio	-	0.79	1.11	1.13	1.03	2.17	Upgrade
Return on Equity (ROE)	-	8.15%	9.42%	-0.74%	25.17%	14.36%	Upgrade
Return on Assets (ROA)	-	1.45%	1.81%	-0.15%	7.24%	7.27%	Upgrade
Earnings Yield	1.56%	2.34%	5.09%	-1.31%	10.86%	8.69%	Upgrade
FCF Yield	-	4.95%	-2.19%	-13.42%	-16.70%	-26.50%	Upgrade
Dividend Yield	0.50%	0.47%	0.81%	1.36%	0.80%	1.40%	Upgrade
Payout Ratio	-	19.90%	16.48%	-	8.87%	17.67%	Upgrade
Buyback Yield / Dilution	3.40%	-2.97%	-21.65%	-18.39%	-8.46%	-4.66%	Upgrade
Total Shareholder Return	3.90%	-2.50%	-20.84%	-17.03%	-7.67%	-3.26%	Upgrade

Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.